CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (Amex: JAV - News), a company focused in the development of prescription products for the treatment of acute pain management, today reported its unaudited financial results for the first quarter ended March 31, 2007.
